Back to Search
Start Over
First-in-Human Assessment of 11 C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer.
- Source :
-
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Apr; Vol. 62 (4), pp. 553-560. Date of Electronic Publication: 2020 Aug 28. - Publication Year :
- 2021
-
Abstract
- This was a first-in-human study of the PET radiotracer <superscript>11</superscript> C-LSN3172176 for the muscarinic acetylcholine receptor subtype M1. The objectives of the study were to determine the appropriate kinetic model to quantify binding of the tracer to M1 receptors, and the reliability of the chosen quantification method. Methods: Six healthy subjects completed the test-retest protocol, and 5 healthy subjects completed the baseline-scopolamine blocking protocol. Multiple modeling methods were applied to calculate total distribution volume ( V <subscript>T</subscript> ) and nondisplaceable binding potential ( BP <subscript>ND</subscript> ) in various brain regions. The reference region was selected from the blocking study. The occupancy plot was applied to compute receptor occupancy by scopolamine and nondisplaceable distribution volume. Results: Tracer uptake was highest in the striatum, followed by neocortical regions and white matter, and lowest in the cerebellum. Regional time-activity curves were fitted well by all models. The 2-tissue-compartment (2TC) model fits were good, but the 2TC parameters often could not be reliably estimated. Because V <subscript>T</subscript> correlated well between the 2TC and 1-tissue-compartment (1TC) models after exclusion of unreliable estimates, the 1TC model was chosen as the most appropriate. The cerebellum showed the lowest V <subscript>T</subscript> , consistent with preclinical studies showing little to no specific binding in the region. Further, cerebellar V <subscript>T</subscript> did not change between baseline and blocking scans, indicating that the cerebellum is a suitable reference region. The simplified reference tissue model (SRTM) slightly underestimated 1TC BP <subscript>ND</subscript> , and the simplified reference tissue model 2 (SRTM2) improved BP <subscript>ND</subscript> estimation. An 80-min scan was sufficient to quantify V <subscript>T</subscript> and BP <subscript>ND</subscript> The test-retest study showed excellent absolute test-retest variability for 1TC V <subscript>T</subscript> (≤5%) and BP <subscript>ND</subscript> (≤10%). In the baseline and blocking studies, occupancy values were lower in the striatum than in nonstriatal regions, as may be attributed to differences in regional acetylcholine concentrations. Conclusion: The 1TC and SRTM2 models are appropriate for quantitative analysis of <superscript>11</superscript> C-LSN3172176 imaging data. <superscript>11</superscript> C-LSN3172176 displayed excellent test-retest reproducibility and is a highly promising ligand to quantify M1 receptors in the human brain.<br /> (© 2021 by the Society of Nuclear Medicine and Molecular Imaging.)
- Subjects :
- Adult
Brain metabolism
Female
Humans
Indoles adverse effects
Indoles chemistry
Kinetics
Ligands
Male
Piperidines adverse effects
Piperidines chemistry
Positron-Emission Tomography adverse effects
Radioactive Tracers
Radiochemistry
Safety
Indoles metabolism
Piperidines metabolism
Positron-Emission Tomography methods
Receptor, Muscarinic M1 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1535-5667
- Volume :
- 62
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 32859711
- Full Text :
- https://doi.org/10.2967/jnumed.120.246967